New Pricing and Expanded DNA Manufacturing Services for 2026

nagene introduces optimized pricing and expanded DNA manufacturing services, including GMP-ready workflows, complex gene synthesis and flexible project options.

As demand for high-quality DNA manufacturing continues to grow, nagene has expanded its service portfolio and optimized its production workflows to provide greater flexibility, transparency and value for customers.

Key updates include:

• Competitive pricing structure for 2026 • GMP-ready DNA manufacturing workflows • Express and Economy synthesis options • Complex gene and plasmid synthesis expertise • Advanced quality control and sequence verification • Scalable support from research through regulated development

Based in Vienna, Austria, nagene supports biotechnology and pharmaceutical companies developing next-generation therapeutics, including gene therapies, mRNA applications and viral vector programs.

Visitors interested in discussing upcoming DNA manufacturing projects are invited to connect with our team.